Evidence map›Paper›PMID 39375459›Full record

ArticleNature medicine2024

Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.

Jennifer M Mitchell, Marcela Ot'alora G, Bessel van der Kolk, Scott Shannon, Michael Bogenschutz, Yevgeniy Gelfand, Casey Paleos, Christopher R Nicholas, Sylvestre Quevedo, Brooke Balliett and 10 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Jennifer M MitchellNeuroscape, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA. jennifer.mitchell@ucsf.edu.ORCID http://orcid.org/0000-0002-7567-8129
Marcela Ot'alora GAguazul-Bluewater, Inc., Boulder, CO, USA.ORCID http://orcid.org/0000-0001-6174-7317
Bessel van der KolkBoston University School of Medicine, Boston, MA, USA.
Scott ShannonWholeness Center, Fort Collins, CO, USA.
Michael BogenschutzDepartment of Psychiatry, New York University Grossman School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0003-4530-3470
Yevgeniy GelfandZen Therapeutic Solutions, Mt. Pleasant, SC, USA.
Casey PaleosNautilus Sanctuary, New York, NY, USA.
Christopher R NicholasDepartment of Family Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Sylvestre QuevedoDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA.
Brooke BalliettNew School Research, LLC, Los Angeles, CA, USA.
Scott HamiltonMAPS Public Benefit Corporation, San Jose, CA, USA.
Michael MithoeferMedical University of South Carolina, Charleston, SC, USA.ORCID http://orcid.org/0000-0002-4267-6135
Sarah KleimanKleiman Consulting and Psychological Services, PC, Ivyland, PA, USA.
Kelly Parker-GuilbertKPG Psychological Services, LLC, Brunswick, ME, USA.
Keren TzarfatyUniversity of Haifa, Haifa, Israel.
Charlotte HarrisonMAPS Public Benefit Corporation, San Jose, CA, USA.
Alberdina de BoerTulip Medical Consulting, LLC, Port Townsend, WA, USA.
Rick DoblinMultidisciplinary Association for Psychedelic Studies (MAPS), San Jose, CA, USA.
Berra Yazar-KlosinskiMAPS Public Benefit Corporation, San Jose, CA, USA.
MAPP2 Study Collaborator Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39375459
PMCPMC11564115

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.